Thoracic stereotactic body radiation therapy plus first-line tyrosine kinase inhibitors for patients with epidermal growth factor receptor-mutant polymetastatic non-small-cell lung cancer-Reference-Cited by-同舟云学术

Thoracic stereotactic body radiation therapy plus first-line tyrosine kinase inhibitors for patients with epidermal growth factor receptor-mutant polymetastatic non-small-cell lung cancer

Published:2021-09-17 Issue:37 Volume:100 Page:e27279
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Wang Xia,Lu Zhiqin,Zeng Zhimin,Cai Jing,Xu Peng,Liu Anwen

Funder

National Natural Science Foundation of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference38 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CACancer J Clin,2018

2. Properties of FDA-approved small molecule protein kinase inhibitors;Roskoski;Pharmacol Res,2019

3. Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update;Roskoski;Pharmacol Res,2021

4. Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC);Gelatti;Lung Cancer (Amsterdam, Netherlands),2019

5. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR-TKIs with or without Stereotactic Body Radiotherapy to Primary Lesion in the Advanced EGFR-Mutated Non- Small Cell Lung Cancer;2024-03-20

2. Additional local therapy before disease progression for EGFR-mutated advanced lung cancer: a systematic review and meta-analysis;Translational Lung Cancer Research;2024-03

3. Predicting the Efficacy of SBRT for Lung Cancer with 18F-FDG PET/CT Radiogenomics;Life;2023-03-27

4. Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy;Clinical and Translational Oncology;2022-09-07

5. The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation;Frontiers in Oncology;2022-05-13